Skip to main content
main-content

Gout and crystal arthropathies

Comorbidities

23-04-2020 | Gout | News

Infection-related hospitalizations on the rise among people with gout

The rate of serious infections requiring hospitalization, particularly sepsis, is increasing among people with gout, US longitudinal study data show.

EULAR 2020 E-Congress hub

Access the latest news and expert video commentary from the EULAR 2020 E-Congress.

13-01-2020 | Gout | News

SGLT2 inhibitors linked to reduced gout risk in diabetes patients

People with type 2 diabetes who are treated with sodium-glucose cotransporter 2 inhibitors are less likely to develop gout than those given glucagon-like peptide-1 receptor agonists, researchers report.

18-12-2019 | Gout | News

Canagliflozin may reduce gout flare risk in people with type 2 diabetes

Treatment with the sodium-glucose cotransporter-2 inhibitor canagliflozin is associated with a reduction in serum urate concentration and gout flare risk among patients with type 2 diabetes, suggests a post-hoc analysis of the CANVAS Program trial.

03-12-2019 | Gout | News

Febuxostat and allopurinol may raise acute kidney injury risk

Febuxostat and allopurinol are associated with an elevated risk for acute kidney injury, according to study results published in Arthritis Research & Therapy.

21-10-2019 | Gout | News

Achieving target sUA levels ‘should be a principal goal’ in hyperuricemic patients with gout

People with gout and hyperuricemia who achieve guideline-recommended serum uric acid levels below 0.36 mmol/L have lower risks for overall and cardiovascular mortality than those who do not meet this target, researchers report.

14-08-2019 | Gout | News

Vaccination may increase gout flare risk

The increased risk for gout flares following receipt of the aluminum-free recombinant zoster vaccine is not unique to this vaccine but is instead associated with vaccination in general, regardless of the adjuvant used, US researchers report.

European recommendations for the diagnosis of gout issued

EULAR has issued eight updated evidence-based recommendations to guide the diagnosis of gout.

10-06-2019 | Gout | Highlight | News

European recommendations for the diagnosis of gout issued

EULAR has issued eight updated evidence-based recommendations to guide the diagnosis of gout.

15-04-2019 | Biomarkers | News

Calprotectin levels separate septic arthritis from other inflammatory arthritides

Levels of calprotectin in the synovial fluid can be used to discriminate patients with septic arthritis from those with pseudogout and rheumatoid arthritis, shows a report published in Rheumatology.

Using genetic studies to assess the impact of hyperuricemia in cardiometabolic and chronic kidney disease

Editorial Board member Fernando Pérez-Ruiz discusses the impact of hyperuricemia in cardiometabolic and chronic kidney disease, focusing on the role of genetic studies in showing a causal association between these conditions.

12-04-2019 | Gout | Editorial | Article

Using genetic studies to assess the impact of hyperuricemia in cardiometabolic and chronic kidney disease

Editorial Board member Fernando Pérez-Ruiz discusses the impact of hyperuricemia in cardiometabolic and chronic kidney disease, focusing on the role of genetic studies in showing a causal association between these conditions.

Highlights from the 2018 ACR/ARHP Annual Meeting

Editorial board members Oliver FitzGerald and Fernando Pérez-Ruiz provide their highlights from the spondyloarthropathy and crystal arthropathy sessions at the 2018 ACR/ARHP Annual Meeting in Chicago, Illinois, USA.

31-10-2018 | Psoriatic arthritis | ACR/ARHP 2018 | Article

From the Editorial Board: Highlights from the 2018 ACR/ARHP Annual Meeting

Editorial board members Oliver FitzGerald and Fernando Pérez-Ruiz provide their highlights from the spondyloarthropathy and crystal arthropathy sessions at the 2018 ACR/ARHP Annual Meeting in Chicago, Illinois, USA.

Hyperuricemia and chondrocalcinosis: A clinical challenge for diagnosis and treatment

Editorial board member Fernando Pérez-Ruiz presents an interesting presentation of coexistant hyperuricemia and chondrocalcinosis, and outlines the challenges of diagnosis and management of these conditions.

18-10-2018 | Crystal arthropathies | Case study | Article

Hyperuricemia and chondrocalcinosis: A clinical challenge for diagnosis and treatment

Editorial board member Fernando Pérez-Ruiz presents an interesting presentation of coexistant hyperuricemia and chondrocalcinosis, and outlines the challenges of diagnosis and management of these conditions.

Allopurinol does not increase CKD risk in patients with gout

Allopurinol, given at a starting dose of at least 300 mg/day, does not increase the risk for chronic kidney disease stage 3 or higher, and may in fact reduce it, in patients with newly diagnosed gout, study data show.

11-10-2018 | Gout | Highlight | News

Allopurinol does not increase CKD risk in patients with gout

Allopurinol, given at a starting dose of at least 300 mg/day, does not increase the risk for chronic kidney disease stage 3 or higher, and may in fact reduce it, in patients with newly diagnosed gout, study data show.

07-09-2018 | Gout | News

Risk for gout in obstructive sleep apnea patients highest after a year

A large cohort study from the UK has confirmed that the risk for gout is increased in people with obstructive sleep apnea, and shows that the risk peaks 1–2 years after diagnosis.

30-08-2018 | Gout | Article

The risk of gout among patients with sleep apnea: A matched cohort study

Blagojevic-Bucknall M et al. Arthritis Rheumatol 2018. doi: 10.1002/art.40662

Image Credits